Accolade Inc
NASDAQ:ACCD
Accolade Inc
NASDAQ:ACCD
Price:
7.54 USD
3.86%
Market Closed
Updated:
May 4, 2024
Accolade Inc
Selling, General & Administrative
|
Accolade Inc
Selling, General & Administrative Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Accolade Inc
NASDAQ:ACCD
|
Selling, General & Administrative
-$280.5m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Selling, General & Administrative
-$1.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-2%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Selling, General & Administrative
-$1.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
|
|
CVS Health Corp
NYSE:CVS
|
Selling, General & Administrative
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Selling, General & Administrative
-$14.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Selling, General & Administrative
-$2.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-6%
|
See Also
What is Accolade Inc's Selling, General & Administrative?
Selling, General & Administrative
-280.5m
USD
-280.5m
USD
Based on the financial report for Feb 28, 2023, Accolade Inc's Selling, General & Administrative amounts to -280.5m USD.
What is Accolade Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-30%
-30%
Over the last year, the Selling, General & Administrative growth was -9%. The average annual Selling, General & Administrative growth rates for Accolade Inc have been -42% over the past three years , -30% over the past five years .
You don't have any saved screeners yet
